Instrument Inactif

Autres langues Intercell AG

Actions

Intercell AG : Annual Report 2011	16/04/12
Intercell AG : Intercell and Statens Serum Institut (SSI) progress vaccine clinical development to fight Tuberculosis	11/01/12
Intercell AG : Thomas Szucs elected new chairman of Intercell’s Supervisory Board	30/12/11
Intercell AG : Intercell and Biological E. Ltd. announce approval for Japanese Encephalitis vaccine in India	10/11/11
Intercell AG : announces Q3 2011 results and provides an update on ongoing operations	08/11/11
Intercell AG : Intercell receives positive scientific advice from EMA for Pseudomonas vaccine Phase II/III-study	12/10/11
Intercell AG : EU invests €30 million to boost vaccine research	29/09/11
Intercell AG : NEW Company Presentation	22/09/11
Intercell AG : Intercell and Biological E announce successful completion of investigational Japanese Encephalitis vaccine pivotal Phase II/III study in India	16/09/11
Intercell AG : Intercell announces Q2 and H1 2011 financial results and provides an update on execution of strategic plan	16/08/11

Aucun résultat pour cette recherche